Results 41 to 50 of about 841,926 (265)

Exploring the Role of Stent Strut Geometry in Cellular Behavior: An In Vitro Chip Model to Understand In‐Stent Restenosis

Advanced Materials Interfaces, EarlyView.
An engineered in vitro platform mimicking stent strut cross‐sectional shapes reveals how geometry influences cell behavior. Sharp‐cornered geometries promote cell proliferation and matrix alignment, while rounded shapes reduce these effects. The findings align with clinical outcomes and suggest intracellular tension as a key driver, offering a ...
Emmie J.D. Schoutens, Juul Verbakel, Heleen M.M. van Beusekom, Jaap M.J. den Toonder, Olaf van der Sluis, Jan de Boer   +5 more
wiley   +1 more source

Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting.

European Heart Journal, 2015
AIM Routine control angiography is a valuable tool with high-sensitivity in detecting restenosis after coronary stenting. However, the prognostic role of restenosis is still controversial.
S. Cassese, R. Byrne, S. Schulz, Petra Hoppman, Johanna Kreutzer, Antonia Feuchtenberger, T. Ibrahim, I. Ott, M. Fusaro, H. Schunkert, K. Laugwitz, A. Kastrati   +11 more
semanticscholar   +1 more source

Red Blood Cell Membrane Lipidomics: Potential Biomarkers Detecting Method for Plasma Volume Overload and Major Adverse Cardiovascular Events in Chronic Heart Failure Patients

Advanced Science, EarlyView.
A novel RBC indicator, ESI, is better than the traditional RBC indicators and is associated with CHF prevalence and in‐hospital death. RBC membrane lipidomics, Cer 18:0;O2/16:0, and LPE 18:0, are associated with plasma volume overload and MACE in CHF patients, but these plasma lipids could not.
Lin Zhang, Xiangqin Ou, Jingyi Lin, Xiaofei Luo, Jiashun Zhou, Xingyue Zhou, Peihua Zhao, Li Liu, Ziran Zhao, Ying Zhou, Guanwei Fan, Lifeng Han, Xiumei Gao   +12 more
wiley   +1 more source

Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease

Biomolecules, 2021
This study investigated the renin-angiotensin-aldosterone system (RAAS) gene polymorphisms as possible genetic risk factors for the restenosis development in patients with drug-eluting stents.
Madina Azova, Kalima Timizheva, Amira Ait Aissa, Mikhail Blagonravov, Olga Gigani, Anna Aghajanyan, Leyla Tskhovrebova   +6 more
doaj   +1 more source

Restenosis after directional coronary atherectomy

Journal of the American College of Cardiology, 1992
This study evaluates the incidence of restenosis after successful directional coronary atherectomy and identifies risk factors for restenosis.Directional coronary atherectomy has been shown to be a safe and effective treatment of obstructive coronary artery disease; however, information regarding restenosis is limited.Between October 1986 and December ...
Dennis J. Sheehan, John B. Simpson, James W. Vetter, Tomoaki Hinohara, Matthew R. Selmon, Lissa J. Braden, Gregory C. Robertson, M. Rowe, Bruce J. McAuley   +8 more
openaire   +3 more sources

Impact of Diabetes on Long‐Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) is a well‐known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
Subin Lim, Soon Jun Hong, Ju Hyeon Kim, Jung‐Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do‐Sun Lim, Chang‐Wook Nam, the COBIS III investigators, Hyo‐Soo Kim, Woo Jung Chun, Seung‐Ho Hur, Seung Hwan Han, Seung‐Woon Rha, In‐Ho Chae, Jin‐Ok Jeong, Jung Ho Heo, Junghan Yoon, Ki Hong Choi, Young Bin Song, Hyeon‐Cheol Gwon, Jong‐Seon Park, Myeong‐Ki Hong, Joon‐Hyung Doh, Kwang Soo Cha, Doo‐Il Kim, Sang Yeub Lee, Kiyuk Chang, So‐Yeon Choi, Myung Ho Jeong, Bon‐Kwon Koo   +31 more
wiley   +1 more source

Experimental models of coronary artery restenosis

Journal of the American College of Cardiology, 1992
The study of potentially effective drug therapies and mechanical devices for the prevention of restenosis after percutaneous coronary revascularization has relied heavily on the use of experimental animal models. To date, greater than 50 experimental studies have been reported and have suggested that at least nine different classes of pharmacologic ...
David W.M. Muller, Stephen G. Ellis, Eric J. Topol   +2 more
openaire   +3 more sources

The First‐in‐Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Treating ostial left circumflex artery (LCx) lesions in percutaneous coronary intervention (PCI) for left main disease (LMD) remains a challenge. Despite recent recommendations for the use of drug‐coated balloon (DCB) in this lesion, there are concerns about crossover‐stenting from the left main trunk (LMT) to the left anterior ...
Takayuki Warisawa, Yoshiki Kawai, Takuya Matsumoto, Shingo Sato, Makoto Takeyama, Yuta Nakamura, Susumu Katsushika, Aritomo Katsura, Takahiro Sato, Masashiro Matsushita, Jiro Ando   +10 more
wiley   +1 more source

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions

Кардиоваскулярная терапия и профилактика, 2007
Coronary restenosis remains the main problem for effectiveness of percutaneous transluminal coronary angioplasty (PCA) and coronary stenting (CS). The aim of this review is to analyze pathogenetic mechanisms of coronary restenosis after PCA and CS, as ...
Yu. A. Shuvalova, A. N. Meshkov, A. I. Kaminny, G. F. Piksina, V. V. Kukharchuk   +4 more
doaj  

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy

Annals of Pediatric Cardiology, 2023
Cardiac allograft vasculopathy (CAV) sometimes leads to restenosis, even after percutaneous transcatheter intervention. Recently, drug-coated balloons (DCBs) have been successfully used to treat coronary artery disease, especially CAVs, in adults ...
Masaki Hirose, Jun Narita, Kazuhisa Hashimoto, Ryo Ishii, Hidekazu Ishida, Keiichi Ozono   +5 more
doaj   +1 more source